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p300-mediated acetylation of the Rothmund-Thomson-syndrome
gene product RECQL4 regulates its subcellular localization
Abstract
RECQL4 belongs to the conserved RecQ family of DNA helicases, members of which play important
roles in the maintenance of genome stability in all organisms that have been examined. Although genetic
alterations in the RECQL4 gene are reported to be associated with three autosomal recessive disorders
(Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes), the molecular role of RECQL4
still remains poorly understood. Here, we show that RECQL4 specifically interacts with the histone
acetyltransferase p300 (also known as p300 HAT), both in vivo and in vitro, and that p300 acetylates
one or more of the lysine residues at positions 376, 380, 382, 385 and 386 of RECQL4. Furthermore, we
report that these five lysine residues lie within a short motif of 30 amino acids that is essential for the
nuclear localization of RECQL4. Remarkably, the acetylation of RECQL4 by p300 in vivo leads to a
significant shift of a proportion of RECQL4 protein from the nucleus to the cytoplasm. This
accumulation of the acetylated RECQL4 is a result of its inability to be imported into the nucleus. Our
results provide the first evidence of a post-translational modification of the RECQL4 protein, and
suggest that acetylation of RECQL4 by p300 regulates the trafficking of RECQL4 between the nucleus
and the cytoplasm.
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Introduction
Genome instability plays a major role in the development and
progression of cancer. All organisms have developed pathways to
mitigate DNA damage by employing enzymes that are involved in
all DNA metabolic processes, including replication, recombination
and repair (Tuteja and Tuteja, 2001). The fundamental importance
of these enzymes, such as DNA helicases and acetyltransferases,
is highlighted by the variety of genetic instability disorders caused
by enzymes defective in these functions (Iyer et al., 2004; Khakhar
et al., 2003).
One family of proteins required to maintain genome stability is
the RecQ helicase family (Hickson, 2003). Humans possess five
RecQ homologues: RECQL1, BLM, WRN, RECQL4 and RECQL5.
Five autosomal recessive disorders (which have been characterized
by genomic instability, cancer progression and developmental
abnormalities) have been associated with defects in the gene
products BLM (causing Bloom syndrome) (Ellis et al., 1995), WRN
(causing Werner syndrome) (Gray et al., 1997) and RECQL4
[causing Rothmund-Thomson (RTS), RAPADILINO and Baller-
Gerold (BGS) syndromes] (Dietschy et al., 2007; Kitao et al., 1999b;
Siitonen et al., 2003; Van Maldergem et al., 2006). RTS is an unusual
autosomal recessive condition and is associated with poikiloderma,
growth deficiency, juvenile cataracts, premature aging and a
predisposition to malignant tumours, particularly osteosarcomas
(Vennos et al., 1992). Interestingly, mutations in the RECQL4 gene
cause only 60% of all RTS cases (Kitao et al., 1999a). Accordingly,
RTS seems to be a heterogeneous disease and mutations in other,
yet unidentified gene(s) seem to be responsible for the phenotype
of the remaining 40% of RTS patients. Mutations found in RECQL4
range from nonsense, frameshift and splice-site mutations to intronic
insertions and deletions (Siitonen et al., 2003). Most of them result
in premature termination of protein translation, yielding truncated
RECQL4 proteins that often lack a large part of the helicase domain
(Lindor et al., 2000). Cells derived from RTS patients show
genomic instability, including trisomy, aneuploidy and chromosomal
rearrangements (Der Kaloustian et al., 1990; Vennos et al., 1992).
Additionally, RTS cells are hypersensitive to ionizing radiation and
oxidative stress (Vennos and James, 1995; Werner et al., 2006).
RAPADILINO syndrome is another autosomal recessive disease
associated with mutations in the RECQL4 gene (Siitonen et al.,
2003). The acronym stands for the characteristic clinical features:
RA for radial hypoplasia or aplasia; PA for patellae hypoplasia or
aplasia, and for cleft or highly arched palate; DI for diarrhoea and
for dislocated joints; LI for little size and for limb malformation;
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NO for slender nose and for normal intelligence. The most common
mutations of the RECQL4 gene in RAPADILINO patients represent
deletions of exon 7, which do not affect the helicase domain of
RECQL4 protein (Siitonen et al., 2003). Although RAPADILINO
patients share some clinical features with RTS patients, such as
photosensitivity with extra pigmentation of skin and growth
deficiency, there are unique diagnostic findings, such as joint
dislocations and patellar hypoplasia or aplasia. In contrast to RTS,
RAPADILINO syndrome is more common in females than in males.
Furthermore, only one out of the 15 RAPADILINO patients
diagnosed so far has developed malignant tumours, mainly
osteosarcomas (Kellermayer et al., 2005). However, to date, no study
has documented the risk of osteosarcoma over time.
BGS is the third recently reported autosomal recessive disorder
linked to mutations in the RECQL4 gene (Van Maldergem et al.,
2006). The clinical hallmarks of BGS are radial aplasia or hypoplasia
and craniosynostosis. To date, most mutations of RECQL4 found in
BGS patients represent a R1021W missense mutation and a 2886
delta T frameshift mutation of exon 9. Surprisingly, none of the 24
BGS patients reported so far showed a predisposition to cancer (Van
Maldergem et al., 2006). Furthermore, the results derived from
experiments involving various RECQL4–/– mice showed that these
mice accumulate defects that clearly reflect the situation in humans,
i.e. different mutations in the RECQL4 gene lead to different
phenotypes (Hoki et al., 2003; Ichikawa et al., 2002; Mann et al.,
2005).
Although the distinct molecular functions of BLM and WRN
helicases have been widely characterized in the last decade, the
precise molecular and cellular role of the RECQL4 protein has not
yet been elucidated. Recent studies suggested an involvement of
RECQL4 protein in DNA replication (Matsuno et al., 2006;
Sangrithi et al., 2005) and repair of DNA double-strand breaks
(DSB) by homologous recombination (HR) (Kumata et al., 2007;
Petkovic et al., 2005), as well as in repair of UV-induced DNA
damage in human cells (Fan and Luo, 2008). The localization of
RECQL4 in different mammalian cells has been studied extensively
(Burks et al., 2007; Kitao et al., 1999a; Petkovic et al., 2005; Woo
et al., 2006; Yin et al., 2004). Several cell biological and
biochemical studies indicated that RECQL4 can be found both in
the nucleus and cytosol of different transformed cell lines (Petkovic
et al., 2005; Yin et al., 2004). In the nucleus, RECQL4 forms
discrete nuclear foci in response to DNA damage, which coincide
with those formed by promyelocytic leukaemia (PML) protein and
Rad51 (Petkovic et al., 2005). Furthermore, upon oxidative damage,
RECQL4 moves to the nucleolus in living HeLa cells, and the
nucleolar localization signal (NOS) was mapped to amino acids
(aa) 376-386 in the RECQL4 sequence (Woo et al., 2006). Recent
findings indicated that RECQL4 aa 363-492 are important for the
nuclear import and localization of RECQL4 protein in different
mammalian cells, whereas aa 420-463 (encoded by exon 7) are
crucial for RECQL4 retention in the nucleus (Burks et al., 2007).
In the cytosol, RECQL4 forms stable complexes with cytosolic
ubiquitin ligases UBR1 and UBR2, which function in the N-end
rule pathway (Yin et al., 2004). However, the exact mechanism of
RECQL4 transport from the nucleus to the cytosol, and the
function of the cytosolic RECQL4 protein, both remain totally
unexplored.
Another class of enzymes, known as acetyltransferases, are also
responsible for maintaining genome stability (Freiman and Tjian,
2003; Hasan and Hottiger, 2002). Histone acetyltransferases (HATs)
catalyze the reversible transfer of an acetyl group from acetyl
coenzyme A to the ε-NH3
+ of lysine residues on core histone tails
(Kuo and Allis, 1998). Traditionally, HATs have been associated
exclusively with the acetylation of histone tails and with
transcriptional regulation through chromatin remodelling. By
alleviating repressive histone-DNA binding, and thus facilitating the
association of transcription factors with DNA, histone acetylation can
lead to increased transcriptional activity (Nakatani, 2001). One such
family of HATs is p300/CBP, which includes the two distinct but
related proteins p300 (also known as p300 HAT and EP300) and
CBP; these proteins participate in many physiological processes,
including proliferation, differentiation and apoptosis (Goodman and
Smolik, 2000). Although p300 was originally identified as acetylating
lysine residues on core histones (Bannister and Kouzarides, 1996;
Ogryzko et al., 1996), in the past decade a growing body of evidence
has suggested that it acetylates other non-histone targets, including
proteins involved in the regulation of transcription, such as p53,
E2F1, EKLF, TFIIEβ, TFIIF, TCF, GATA1, HMGI(Y) and ACTR
(Kouzarides, 2000), as well as DNA-repair and -replication proteins,
such as PCNA (Hasan et al., 2001a), FEN-1 (Hasan et al., 2001b),
TDG (Tini et al., 2002), APE1 (Bhakat et al., 2003), NEIL2 (Bhakat
et al., 2004), DNA polymerase-β (Hasan et al., 2002) and human
8-oxoguanine-DNA glycosylase (OGG1) (Bhakat et al., 2006).
Acetylation by p300 can modulate the activity of DNA-repair and -
replication proteins, either positively or negatively. For example,
acetylation of FEN1 by p300 reduces the nuclease activity of FEN1,
presumably as a result of reduced DNA binding (Hasan et al., 2001b).
Similarly, acetylation of NEIL2, an oxidized pyrimidine-specific DNA
glycosylase, was shown to inhibit its enzymatic activity (Bhakat et
al., 2004). By contrast, acetylation of human OGG1 by p300
significantly increases the activity of OGG1 activity in vitro in the
presence of AP-endonuclease by reducing its affinity for the abasic
(AP) site product (Bhakat et al., 2006). Also, p300-mediated
acetylation of WRN enhances its helicase and exonuclease activities
in vitro and regulates the function of WRN in base excision repair
(Muftuoglu et al., 2008). All these examples highlight the importance
of p300 in the DNA base excision repair process.
In spite of several recent studies showing that acetylation of DNA
repair and replication proteins by p300 results in altered DNA repair
and substrate specificity, acetylation of RECQL4 as well as its
physiological relevance have not been addressed so far. In this paper,
we report the physical and functional interaction between RECQL4
and p300. p300 specifically acetylates RECQL4 on a stretch of
lysine residues, previously shown to function as the NOS-NLS
(nucleolar and/or nuclear localization signal) sequence of RECQL4
(Burks et al., 2007; Woo et al., 2006). Furthermore, we demonstrate
that mutation of these lysine residues to alanine (Lys 376, 380, 382,
385, 386 Ala), but not to arginine (Lys 376, 380, 382, 385, 386
Arg), completely abolishes the nuclear import of RECQL4 in human
cells. Additionally, fusion of the RECQL4 aa 376-386 to the N-
terminus of β-galactosidase leads to the nuclear import of this 100-
kDa protein in mammalian cells, indicating the importance of the
positively charged amino acid residues for the nuclear import of
the RECQL4 protein. Overexpression of p300, but not the
catalytically dead mutant (p300 HAT), leads to a significant
accumulation of RECQL4 protein in the cytoplasm. The same effect
could be observed by treating the cells with histone deacetylase
(HDAC) inhibitors trichostatin A (TSA) and nicotinamide (NA),
suggesting that acetylation of RECQL4 by p300 is involved in the
RECQL4 cytoplasmic localization. Taken together, our data help
to understand the mechanism by which RECQL4 is localized to the
cytoplasm in mammalian cells.
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Results
In vivo acetylation of RECQL4 by p300 and interaction of the
full-length proteins
We wanted to investigate whether RECQL4 is acetylated in
mammalian cells. To identify a potential acetyltransferase that
acetylates RECQL4 in vivo, RECQL4 containing (His)6-Xpress
epitope tag was overexpressed in HEK 293T cells with each of
the four major human acetyltransferases (p300, PCAF, GCN5 and
HAT1). Notably, we were forced to use overexpressed RECQL4
protein in this assay owing to a low expression level of the
endogenous RECQL4 gene. An Omni-probe antibody raised
against a peptide mapping between the (His)6 and the polylinker
sequence of Xpress vectors was used to immunoprecipitate the
recombinant RECQL4 protein from whole-cell extracts (Fig. 1A,
upper left panel). A control IgG antibody failed to precipitate
RECQL4 and confirmed the specificity of the Omni-probe
antibody for (His)6-Xpress-RECQL4 (Fig. 1A, lane 6). The
acetylation status of RECQL4 was visualized by western blot
analysis using an antibody recognizing acetylated lysines (Fig.
1A, lower left panel). Although western blot analysis revealed
that all four acetyltransferases (p300, PCAF, GCN5 or HAT1) were
expressed to similar levels (Fig. 1A, right panel), RECQL4 was
found to be strongly acetylated only in cells overproducing p300,
suggesting that p300 might be an acetyltransferase that acetylates
RECQL4 in vivo. Additionally, neither cell-cycle status nor
treatment with different DNA damaging agents (cisplatin,
campthotecin, etoposide) significantly affected RECQL4
acetylation in vivo (supplementary material Fig. S1A,B).
We next analyzed whether RECQL4 and p300 interact in human
cells. Because we could not detect complex formation between
endogenous RECQL4 and p300 owing to a low expression level
of both proteins, we switched to the overexpression approach. For
this, FLAG-p300 and (His)6-Xpress-RECQL4 expression constructs
were transiently transfected into HEK 293T cells, and the total cell
extract was immunoprecipitated with Omni-probe antibody and
analyzed by immunoblotting using an anti-FLAG antibody. We
found that FLAG-p300 was efficiently co-precipitated with (His)6-
Xpress-RECQL4 (Fig. 1B, lane 3), but was not detected when the
control IgG antibody was used (Fig. 1B, lane 2). Notably, 500 μg
of whole cell extract needed to be used in order to detect the
interaction, which might be because of the transient nature of
the interaction between p300 and RECQL4. To further confirm
the interaction between RECQL4 and p300 in human cells, the
reciprocal co-immunoprecipitation experiment was carried out
using a FLAG-antibody. (His)6-Xpress-RECQL4 could be
specifically co-immunoprecipitated with FLAG-p300 (Fig. 1B, lane
6), but not with the control IgG antibody (Fig. 1B, lane 5). It should
be noted that cell extracts used in the above-mentioned experiments
were supplemented with ethidium bromide, excluding the possibility
that association of RECQL4 and p300 is mediated by DNA.
We next performed an ELISA-based protein-binding assay using
purified recombinant proteins to determine whether RECQL4 and
p300 interact directly. Increasing concentrations of purified
recombinant RECQL4 (0-40 nM) were incubated in wells that had
been precoated with purified p300 at a concentration of 20 nM and
subsequently blocked with BSA to prevent nonspecific interactions.
After extensive washing, the bound RECQL4 was incubated with
a specific anti-RECQL4 polyclonal antibody, followed by a
colorimetric assay to quantify the binding. In control experiments,
RECQL4 was incubated in wells precoated only with BSA. We
found that RECQL4 was bound to p300-coated wells in a dose-
Journal of Cell Science 122 (8)
dependent manner, but was not bound in wells precoated with BSA,
indicating a direct interaction (Fig. 1C).
Taken together, these data indicate that p300 acetylates RECQL4
in vivo, that RECQL4 and p300 form a complex in human cells,
and that the proteins interact directly in vitro.
Mapping of the RECQL4 and p300 interaction regions
To map the p300-interaction domain in RECQL4, RECQL4 was
divided into four fragments (RECQL4-1 to RECQL4-4), which were
Fig. 1. p300 acetylates RECQL4 in vivo and the two proteins form a stable
complex. (A) Left panel: (His)6-Xpress-RECQL4 was ectopically expressed in
HEK 293T cells along with FLAG-p300, myc-PCAF, HA-GCN5 or FLAG-
HAT1 histone acetyltransferases (HATs). (His)6-Xpress-RECQL4 was then
immunoprecipitated (IP) with Omni-probe antibody (α-Omni) and analyzed
by western blot (upper panel). The same nitrocellulose membrane was stripped
and re-probed with anti-acetyl-lysine (α-Ac-Lys) antibody (lower panel).
Right panel: western blot analysis of overexpressed HATs (FLAG-p300, myc-
PCAF, HA-GCN5 and FLAG-HAT1–FLAG-p46 heterodimer). Total protein
extract (50 μg) was loaded in each lane. The same amount of extract from
mock-transfected HEK 293T cells was analyzed as a negative control (–).
(B) RECQL4 and p300 form a complex in human cells. Left panel: HEK 293T
cells were transiently transfected with FLAG-p300 expression vector. Total
cell extract derived from these cells was immunoprecipitated with anti-
RECQL4 antibody (α-RECQL4) or control IgG (IgGctrl) and analyzed by
SDS PAGE. One-tenth (100 μg) of the same total cell extract was used as input
control (lane 1). Immunoprecipitated FLAG-p300 and RECQL4 were detected
by western blotting using anti-FLAG (α-FLAG) and anti-RECQL4 (α-
RECQL4) antibody, respectively (lane 3). Reciprocal co-immunoprecipitation
is shown in the right panel: lane 4, input; lane 5, immunoprecipitation with the
control IgG; lane 6, immunoprecipitation with anti-p300 antibody (α-p300)
using total cell extracts derived from HEK 293T cells overexpressing (His)6-
Xpress-RECQL4. (C) Binding of RECQL4 to p300 as a function of RECQL4
concentration. Increasing concentrations of RECQL4 (0–40 nM) were
incubated at 37°C for one hour in wells of an ELISA plate that were pre-coated
with the p300 protein (20 nM) and subsequently blocked with 3% BSA. After
extensive washing, bound RECQL4 protein was detected as described in the
Materials and Methods. Absorbance values were corrected by subtracting
background values obtained with BSA-coated wells. Triangles represent the
average of measurements from duplicate samples.
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1119RECQL4 acetylation by p300
cloned and expressed as fusions with glutathione S-transferase
(GST) (Fig. 2A,B). GST pull-down experiments with these
fragments were performed using total extract from HEK 293T cells
overexpressing FLAG-p300. Western blot analysis of bound proteins
using anti-FLAG antibody indicated that only RECQL4-2 was able
to interact with full-length p300 (Fig. 2C, lane 4). This fragment
spans aa residues 1-408 of RECQL4 and contains the RECQL4
NOS sequence previously mapped to aa 376-386 (Woo et al., 2006)
and a part of the helicase domain (see also Fig. 2A).
To map the RECQL4-interaction region in p300, p300 was also
divided into several fragments (p300-1 to p300-5), which were
subsequently expressed and purified as GST fusions (Fig. 2D,E).
GST pull-down experiments were performed using whole cell
extracts of HEK 293T cells overproducing (His)6-Xpress-RECQL4.
Western-blot analysis of bound proteins using Omni-probe antibody
indicated that only p300-4 was able to interact with RECQL4 (Fig.
2F, lane 6). This fragment spans aa 1459-1892 and contains a part
of the p300 HAT domain that was previously shown to interact with
human FEN-1 (Hasan et al., 2001b).
Identification of acetylation sites of RECQL4
Several studies revealed that p300 preferentially acetylates stretches
of lysine residues of substrate proteins (Bai et al., 2005; Faiola et
al., 2007; Hasan et al., 2001b; Hassa et al., 2005; Topper et al.,
2007). The RECQL4 amino-acid sequence contains 32 lysine
residues, and the only lysine stretch is located in the previously
Fig. 2. Mapping of interaction domains between p300 and RECQL4.
(A) Schematic representation of RECQL4 and its deletion variants used in this
study. (B) SDS-PAGE analysis of bacterially expressed and purified GST-
RECQL4 fragments 1-4. Gel was stained with Coomassie blue. (C) GST pull-
down assay showing binding of FLAG-p300 to bacterially expressed GST-
RECQL4 fragments 1-4. GST-RECQL4 fragments bound to glutathione-
Sepharose beads were incubated with whole cell extract (500 μg of total
protein) derived from HEK 293T cells overexpressing FLAG-p300. Binding of
p300 was analyzed by western blotting using anti-FLAG antibody (α-FLAG).
Enhanced chemiluminescence (ECL) reagent was used for detection, and the
film was exposed for 2 minutes. (D) Schematic representation of p300 and its
deletion variants (p300-1 to p300-5). (E) SDS-PAGE analysis of bacterially
expressed and purified GST-p300 fragments 1–5. (F) GST pull-down assay
showing binding of RECQL4 to bacterially expressed GST-p300 fragments
1–5. GST-p300 fragments bound to glutathione-Sepharose beads were
incubated with whole cell extract (1 mg of total protein) derived from HEK
293T cells overexpressing (His)6-Xpress-RECQL4. RECQL4 binding was
analyzed by western blotting using Omni-probe antibody (α-Omni).
Fig. 3. Mutation of lysine residues 376, 380, 382, 385 and 386 abrogates the
acetylation of RECQL4 by p300 in vitro and in vivo. (A) Amino-acid
sequence of RECQL4 NOS. Wild-type sequence is highlighted in yellow with
lysine residues in red. Lysine to alanine (KrA) mutated NOS sequence and
lysine to arginine (KrR) mutated NOS sequence of RECQL4 were generated
by site-directed mutagenesis. Mutated residues are in red. (B) Left panel:
Effect of mutation of lysine residues of RECQL4 NOS on in vivo acetylation
of RECQL4. Using Omni-probe antibody (α-Omni), the wild-type (WT),
KrA and KrR nucleolar localization signal mutants of (His)6-Xpress-
RECQL4 were immunoprecipitated (IP) from extracts of HEK 293T cells co-
transfected with p300 expression vector (+) or control vector (–) (upper panel).
Acetylated (His)6-Xpress-RECQL4 was detected by western blot analysis
using anti-acetyl lysine antibody (α-Ac-Lys) (lower panel). Right panel: Same
as left panel, but the effects of single (K382R), double (K385, 386R) and triple
(K376, 380, 382R) RECQL4 NOS mutations on in vivo acetylation of
RECQL4 were tested. (C) Schematic representation of RECQL4 and its
deletion variants used in this study (RECQL4-a to RECQL4-e). Numbers in
italics indicate terminal amino acid positions. Solid black box, NOS; striped
box, NOS with five lysine-to-alanine point mutations; green box, RecQ DNA
helicase domain. (D) p300 purified from insect cells was incubated with [14C]
acetyl coenzyme A and with purified GST-RECQL4 fragments or purified
histone octamers. Left panel shows the Coomassie-blue-stained SDS-PAGE
gel, and the right panel shows the autoradiogram of the same gel. Asterisks
indicate protein bands with the predicted molecular mass of the corresponding
purified GST-RECQL4 fragment.
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identified NOS sequence of RECQL4, with five lysine residues at
positions 376, 380, 382, 385 and 386 (Woo et al., 2006). Two
RECQL4 NOS mutants, with all five lysine residues mutated to
either alanine (KrA) or to arginine (KrR), were generated using
site-directed mutagenesis in order to identify the extent of
acetylation of the NOS lysine residues within RECQL4 (Fig. 3A).
Wild-type, KrA or KrR (His)6-Xpress-RECQL4 were
subsequently expressed in HEK 293T cells in the presence or
absence of FLAG-p300, and immunoprecipitated from whole cell
extracts using Omni-probe antibody (Fig. 3B, upper left panel). A
control IgG serum confirmed the specificity of the Omni-probe
antibody for (His)6-Xpress-RECQL4 in the immunoprecipitation
reaction (Fig. 3B, lane 7). The extent of RECQL4 acetylation was
visualized by western-blot analysis using an anti-acetylated lysine
antibody (Fig. 3B, lower left panel). Although co-expression of wild-
type RECQL4 and p300 resulted in acetylation of RECQL4 (Fig.
3B, lane 6), the acetylation of the KrA (Fig. 3B, lane 2) and KrR
(Fig. 3B, lane 4) mutants of RECQL4 was not detected, suggesting
that at least one of the lysine residues at positions 376, 380, 382,
385 and 386 of RECQL4 is required for acetylation by p300. To
further investigate which of the five lysine residues is acetylated
in vivo, we generated single (K382R) (Fig. 3B, lanes 9 and 10),
double (K385,386R) (Fig. 3B, lanes 11 and 12) and triple
(K376,380,382R) (Fig. 3B, lanes 13 and 14) mutants of RECQL4
by site-directed mutagenesis. The three mutants were co-transfected
in the presence or absence of p300 in HEK 293T cells and analyzed
as described above (Fig. 3B, left panel). Co-transfection of all three
mutants and p300 resulted in acetylation of RECQL4 (Fig. 3B, lanes
10, 12 and 14), suggesting that more than one of the lysine residues
at positions 376, 380, 382, 385 and 386 is acetylated by p300.
To confirm that the stretch of lysine residues in RECQL4 at
positions 376, 380, 382, 385 and 386 is acetylated by p300,
RECQL4 was divided into several fragments (RECQL4-a to
Journal of Cell Science 122 (8)
RECQL4-e) that were subsequently expressed and purified as GST
fusion proteins (Fig. 3C). Subsequently, p300 purified from SF9
insect cells was incubated with the above-mentioned GST-RECQL4
fragments and [14C] acetyl coenzyme A. The reactions were
analyzed by SDS PAGE. After staining with Coomassie blue (Fig.
3D, left panel), the gel was subjected to autoradiography and
revealed that p300 was self-acetylated and was able to acetylate
fragment RECQL4-b (Fig. 3B, right panel). This fragment spans
amino acid residues 359-478, including the putative NOS sequence
(aa 376-386) of RECQL4. Furthermore, this fragment also contains
a part of the p300 interaction region (aa 1-408) that was mapped
in the experiment shown in Fig. 2B. Importantly, there was no
detectable acetylation of RECQL4-c, which covers the same region
as RECQL4-b but has all five lysine residues mutated to alanines.
The difference in electrophoretic mobilities of fragments b and c
can be explained by the lack of positive charge in the alanine mutant.
It should be noted that Coomassie-blue staining of the gel confirmed
that comparable amounts of RECQL4 fragments were used in each
acetylation reaction (Fig. 3D).
Thus, we conclude from the in vivo and in vitro acetylation assays
that p300 acetylates RECQL4 on one or more of the lysine residues
at positions 376, 380, 382, 385 and 386, previously characterized
as the NOS-NLS sequence.
Role of lysine residues 376, 380, 382, 385 and 386 in
RECQL4 localization in mammalian cells
We next investigated the functional significance of acetylation of
lysine residues 376, 380, 382, 385 and 386 by analyzing the
subcellular distribution of RECQL4 protein in human cells. To that
end, we transiently overexpressed (His)6-Xpress-RECQL4 in HeLa
cells and examined its subcellular localization by indirect
immunofluorescence using an Omni-probe antibody (Fig. 4A, top
row). We found that, in 70% of the cells, RECQL4 was localized
Fig. 4. Mutation of RECQL4 lysine residues Lys376, Lys380,
Lys382, Lys385 and Lys386 to alanine (KrA), but not to arginine
(KrR), causes relocalization of RECQL4 to the cytoplasm of
human cells. (A) (His)6-Xpress-RECQL4 and the indicated
(His)6-Xpress-RECQL4 KrR and KrA mutants were expressed
in HeLa cells and visualized by indirect immunofluorescence
using Omni-probe antibody (α-Omni) (red, centre column). The
left column shows DAPI-stained nuclei (blue) and the right
column shows the merged images. (B) The histograms show the
percentage of transfected cells that show an equal distribution of
RECQL4 between nucleus and cytoplasm (N=C), a prevalence of
RECQL4 in the cytoplasm (N<C) or a prevalence of RECQL4 in
the nucleus (N>C). The plotted data indicate the mean ± s.d. of
two independent transfection experiments in which more than
200 transfected cells were analyzed each time. (C) Schematic
representation of the RECQL4 NLS–β-galactosidase fusion
constructs. Nucleotides encoding the RECQL4 amino-acid
sequence 376-386 (wild type) and the indicated KrA mutant
version of this sequence were C-terminally fused to the full-
length cDNA of the E. coli lacZ gene and the fusion proteins were
transiently expressed in HeLa cells. (D) β-galactosidase and the
indicated fusion constructs (NLS β-Gal and NLS KrA  β-Gal)
were transiently transfected into HeLa cells and expressed
proteins were visualized by indirect immunofluorescence using
anti-β-galactosidase antibody (red, centre column). DAPI-
staining (blue) is shown in the left column, and merged pictures
(Merge) are shown in the right column. (E) Quantitative analysis
as in B. Scale bars: 10 μm.
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predominantly in the nucleus. In 22% of the cells, RECQL4 was
equally distributed between nucleus and cytoplasm. In 8% of the cells,
predominant cytoplasmic localization of RECQL4 protein was
observed (Fig. 4B, bars on the left). Our observation is consistent
with previously published biochemical and immunofluorescence data
on overexpressed and endogenous RECQL4, showing that RECQL4
is found both in the nucleus and in the cytoplasm of the different cell
lines examined (Burks et al., 2007; Petkovic et al., 2005; Yin et al.,
2004). Therefore, we considered the (His)6-Xpress-RECQL4 fusion
protein to be an adequate tool for further characterization of the
cellular localization of RECQL4. We next studied the localization of
the KrA and KrR mutants of RECQL4 in HeLa cells, because
the RECQL4 N-terminal basic motif spanning aa 376-386
(KQAWKQKWRKK) was previously reported to have nucleolar-
localization activity (Woo et al., 2006). Each of the mutants were
transiently transfected in HeLa cells and the expressed proteins were
detected by indirect immunofluorescence using Omni-probe antibody
(Fig. 4A, middle and bottom rows). No significant difference in
subcellular localization between the wild-type RECQL4 and its KrR
mutant was observed (Fig. 4A, middle row; Fig. 4B, centre
histograms). Interestingly, the RECQL4 KrA mutant was mostly
localized to the cytoplasm of HeLa cells. Similar results were obtained
using U2OS cells, and cell-type-specific observations could therefore
be excluded (supplementary material Fig. S2). Importantly, our
findings seem contradictory to the observations of Woo et al., who
found nucleolar exclusion (but nucleoplasmic localization) of GFP-
RECQL4 lacking the basic motif (Woo et al., 2006). To further verify
the validity of our results, we fused the nucleotides encoding the basic
motif (aa 376-386) of RECQL4 (NLS) or the KrA mutant sequence
(NLS KrA) N-terminally to the Escherichia coli lacZ cDNA (to
give the proteins NLS β-Gal and NLS KrA β-Gal, respectively; Fig.
4C). Transiently overexpressed E. coli β-galactosidase localized
almost entirely to the cytoplasm in HeLa cells (Fig. 4D, top row;
Fig. 4E). Intriguingly, the RECQL4 wild-type basic motif fused to
the β-galactosidase protein was able to import this 100-kDa protein
to the nucleus (Fig. 4D, middle row; Fig. 4E), whereas the NLS KrA
β-galactosidase fusion protein localized mostly to the cytoplasm (Fig.
4D, bottom row; Fig. 4E). Similar results were obtained using HEK
293T cells (supplementary material Fig. S3). Thus, we conclude from
this experiment that positively charged side chains of lysine residues
376, 380, 382, 385 and 386 within the N-terminal basic motif
(KQAWKQKWRKK) are essential for the nuclear localization of
RECQL4.
RECQL4 accumulates in the cytoplasm upon acetylation by
p300
We next wanted to examine the cellular localization of RECQL4
protein in human cells that express either the wild-type or mutated
p300. We first transiently expressed, in HeLa cells, FLAG-p300
and FLAG-p300ΔHAT, a catalytically dead mutant lacking part of
the HAT domain, and visualized both proteins by indirect
immunofluorescence. As expected, both proteins were localized
entirely to the nucleus of HeLa cells (Fig. 5A). We then investigated
the functional consequence of the RECQL4 acetylation in vivo.
Immunofluorescence experiments on co-transfected HeLa cells
[(His)6-Xpress-RECQL4–FLAG-p300 and (His)6-Xpress-
RECQL4–FLAG-p300ΔHAT] showed that the catalytic activity of
p300 enhances the number of cells in which RECQL4 is mainly
cytoplasmic by about threefold (Fig. 5B,C). In accordance with this
observation, p300 catalytic activity did not drive the accumulation
of RECQL4 KrR mutant in the cytoplasm, confirming that these
lysine residues are responsible for p300-induced RECQL4 re-
localization to cytoplasm (Fig. 5D,E). We conclude that
overexpression of the catalytically dead mutant of p300 (FLAG-
Fig. 5. p300 activity-dependent accumulation of
RECQL4 protein in the cytoplasm. (A) p300 and
p300 HAT, a catalytic dead mutant, localize to the
nucleus in mammalian cells. FLAG-tagged p300 or
FLAG-p300 HAT proteins were transiently
expressed in HeLa cells and visualized by indirect
immunofluorescence using anti-FLAG antibody
(green, centre column). DAPI-stained nuclei are
shown in the left column (blue), and the merged
pictures (Merge) are shown in the right column.
(B,D) (His)6-Xpress-RECQL4 (B) or its KrR
mutant (D) were co-expressed with FLAG-p300 or
FLAG-p300 HAT proteins in HeLa cells.
RECQL4 proteins were visualized with Omni-
probe antibody (α-Omni; red), and the p300 and
p300 HAT proteins were visualized with anti-
FLAG antibody (α-FLAG; green). DAPI-staining
(blue) shows nuclear DNA. Right-hand column
show merged pictures (Merge).
(C,E) Quantification of B and D. The histograms
show the percentage of cells (out of transfected
cells) that show an equal distribution of RECQL4
between nucleus and cytoplasm (N=C), a
prevalence of RECQL4 in the cytoplasm (N<C) or
a prevalence of RECQL4 in the nucleus (N>C).
The plotted data represent the mean ± standard
deviation of two independent transfection
experiments in which more than 200 transfected
cells were analyzed each time. Scale bars: 10 μm.
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p300ΔHAT) leads to a dominant negative effect, preventing
endogenous p300 from acetylating RECQL4.
Histone deacetylase inhibitors cause RECQL4 to accumulate
in the cytoplasm
To further confirm that the observed cytoplasmic accumulation of
RECQL4 is indeed caused by its acetylation, HeLa cells were
transfected with (His)6-Xpress-RECQL4 or (His)6-Xpress-RECQL4
KrR expression vectors and incubated for 30 hours in the presence
of the histone-deacetylase inhibitors TSA and NA. As shown in
Fig. 6A,B, treatment with both TSA and NA led to increased levels
of RECQL4 protein in the cytoplasm, although the localization of
the RECQL4 KrR mutant was not affected. These findings indicate
that protein acetylation, enhanced by TSA and NA, is the driving
force behind the RECQL4 cytoplasmic localization. Similar results
were obtained when U2OS cells were used instead of HeLa cells
(data not shown).
Collectively, these data imply that the subcellular localization of
RECQL4 is regulated at least in part by acetylation and that p300
acetyltransferase activity on the lysine residues within the RECQL4
basic motif (KQAWKQKWRKK) is crucial for its accumulation in
the cytoplasm.
Discussion
Although RTS, RAPADILINO and BGS syndromes caused by
mutations in RECQL4 are rare (i.e. they currently affect
approximately 400 individuals in total), from a molecular biology
aspect it is important to investigate how faulty RECQL4 hinders
the normal processes of DNA repair and replication, and how defects
in these processes lead to the broad spectrum of clinical features
observed in RTS, RAPADILINO and BGS patients.
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RECQL4 subcellular localization has been the object of extensive
studies in the last couple of years (Burks et al., 2007; Kitao et al.,
1999a; Petkovic et al., 2005; Woo et al., 2006; Yin et al., 2004).
Different data suggested that RECQL4 is located in the nucleus and
the cytoplasm of the different cell lines examined, but the molecular
mechanism by which RECQL4 is translocated to the cytoplasm and
the cytoplasmic function of RECQL4 both remain to be elucidated.
Our study provides evidence of a physical and functional interaction
between RECQL4 and p300 (a transcriptional coactivator and
histone acetyltransferase). We show in vitro and in vivo that p300
acetylates RECQL4 on several lysine residues of the conserved N-
terminal basic motif spanning aa 376-386 (KQAWKQKWRKK),
and that this acetylation leads to cytoplasmic accumulation of
RECQL4. Because p300 catalytic activity did not drive the
accumulation of RECQL4 KrR mutant in the cytoplasm, our data
indicate that acetylated lysine residues 376, 380, 382, 385 and 386
of RECQL4 are crucial for the cytoplasmic localization of RECQL4
in the two different human cell lines examined. In addition, the
exposure of these cell lines to histone deacetylase inhibitors TSA
and NA (both of which increase the level of protein acetylation)
induced the cytoplasmic localization of the wild-type RECQL4 but
not of the RECQL4 KrR mutant. This further confirmed the
importance of the lysine residues 376, 380, 382, 385 and 386 of
RECQL4.
We also showed that lysine residues 376, 380, 382, 385 and
386 of RECQL4 within the N-terminal basic motif
(KQAWKQKWRKK) are essential for the nuclear localization of
RECQL4. In accordance with our data, Burks et al. demonstrated
that RECQL4 aa 363-492 are crucial for nuclear import and
localization of GFP-RECQL4, and that a conserved block of 22
amino acids (aa 365-386) was able to import GFP to the nucleus
of mammalian cells (Burks et al., 2007). These authors also showed
that a conserved motif (VLPLV) within the RECQL4 region
spanning aa 420-463 (encoded by exon 7) might play a role in
nuclear retention of the RECQL4 protein. By contrast, Woo et al.
observed nucleoplasmic localization of GFP-RECQL4 lacking the
basic motif (Woo et al., 2006), which could be explained by the
possibility that deleting this region influences the proper folding of
RECQL4 and expose a second NLS. This is consistent with work
by Burks et al. that identified an additional nuclear localization
activity at the N-terminus of RECQL4 (Burks et al., 2007). Further
studies are needed, however, to clarify this issue.
Furthermore, we have shown that acetylation of RECQL4 by
p300 does not significantly change during the cell cycle or upon
cellular treatment with different DNA damaging agents, including
cisplatin, etoposide and camptothecin. In agreement with these
findings, it has been demonstrated that DNA damage does not
significantly affect subcellular localization of RECQL4 (Woo et al.,
2006). By contrast, DNA damage by either UV light or ionizing
radiation induces p300-dependent WRN translocation from
nucleolus to nuclear foci (Blander et al., 2002).
We would like to point out that all of our localization experiments
were performed with transiently overexpressed RECQL4 and,
although it is known that overexpression of proteins might lead to
artifactual localization results, previous work with HeLa cells (i.e.
the cell used in our study) has shown that the subcellular distribution
of ectopically expressed RECQL4 is similar to that of endogenous
RECQL4 (Burks et al., 2007). It is reasonable, therefore, to conclude
that our localization data are reflective of wild-type conditions.
Further studies are needed to understand, at the molecular level,
which endogenous and exogenous factors are required to trigger
Fig. 6. Histone deacetylase inhibitors trichostatin A and nicotinamide promote
translocation of RECQL4 to the cytoplasm. (A) (His)6-Xpress-RECQL4 and
(His)6-Xpress-RECQL4 KrR mutant were transiently overexpressed in HeLa
cells. Trichostatin A (TSA) and nicotinamide (NA) were added 24 hours post-
transfection and the cells left for an additional 30 hours. Cells were
subsequently fixed and expressed proteins were visualized as in Fig. 4A.
(B) Quantification of A. The plotted data indicate the mean ± standard
deviation of two independent transfection experiments in which more than 200
transfected cells were analyzed each time. Scale bar: 10 μm.
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p300-dependent acetylation of RECQL4. For example, it is possible
that deacetylation of RECQL4 by the as-yet-unidentified deacetylase
regulates its acetylation status. Indeed, Li et al. recently reported
that deacetylation of WRN helicase by the SIRT1 deacetylase
regulates WRN-mediated cellular responses to DNA damage (Li et
al., 2008). Additional experiments are planned in our laboratory to
determine the possible effects of deacetylation of RECQL4 on its
cellular localization and other roles in DNA metabolism.
Exactly how p300 regulates the subcellular localization of
RECQL4 is an intriguing problem. As shown in Fig. 5A, p300 is
localized exclusively to the nucleus of HeLa cells. Therefore, we
hypothesize that the acetylation of RECQL4 by p300 takes place
in the nucleus, followed by subsequent export of the acetylated
RECQL4 to the cytoplasm. Once in the cytoplasm, the acetylation
of the RECQL4 NLS prevents the helicase from being imported
into the nucleus again, leading to its accumulation in the cytoplasm.
As shown in Fig. 6A,B, treatment of cells with HDAC inhibitors
TSA and NA, thus shifting RECQL4 towards an acetylated state,
led to an accumulation of RECQL4 in the cytoplasm. Our hypothesis
is further supported by previous work showing that p300-mediated
acetylation of the transcription factors HMGB1 (Bonaldi et al.,
2003) and E1A (Madison et al., 2002) negatively affects the function
of their NLS, thus disrupting their association with the nuclear
import machinery and leading to subsequent cytoplasmic
accumulation of these transcription factors. Furthermore, we would
like to emphasize that the RECQL4 KrA mutant, mimicking the
acetylated state of the RECQL4 NLS by charge depletion, could
not be imported to the nucleus in the different cell lines examined.
It has been recently demonstrated that RECQL4 is found in
complex with UBR1 and UBR2, at least partially, in cytosolic
extracts of HeLa cells (Yin et al., 2004). UBR1 and UBR2 belong
to the family of E3 ubiquitin ligases, which is part of the ubiquitin
proteasome system (Hershko et al., 2000). It is therefore tempting
to speculate that, after a portion of RECQL4 is acetylated by p300
in the nucleus, RECQL4 is translocated to the cytoplasm where the
interaction with UBR1 and UBR2 takes place and leads to a
subsequent degradation by the proteasome. Finally, we note that
we cannot, at the present time, rule out the possibility that RECQL4
has some other role in the cytosol that still awaits further
investigations.
Materials and Methods
Plasmid construction
Full-length RECQL4 cDNA was subcloned in the mammalian expression vector
pcDNA3.1/HisC (Invitrogen) between EcoRI and XhoI sites to generate N-terminal
fusion of RECQL4 with a (His)6-Xpress epitope tag. This construct was subsequently
used for all immunofluorescence experiments. The mammalian expression vector for
FLAG-p300 was described previously (Hasan et al., 2001a). Various portions of the
RECQL4 cDNA (Fig. 2A) were amplified by PCR and cloned in pGEX6P1 (GE
Healthcare) between EcoRI and SalI sites to generate N-terminal fusions with
glutathione-S-transferase (GST). These constructs were used for the GST-pulldown
experiments. pGEX6P2 derivatives expressing various p300 fragments (Fig. 2D) as
N-terminal fusions with GST were described previously (Hasan et al., 2001a).
For purification of full length RECQL4, the RECQL4 cDNA was cloned in pET21b
vector (Novagen) between the NheI and XhoI restriction sites to generate a C-terminal
fusion of RECQL4 with a (His)6 tag. Subsequently, a DNA fragment encoding for
GST was cloned between the NdeI and NheI sites of the pET21b-RECQL4 plasmid,
resulting in a construct encoding for a GST-RECQL4-(His)6 fusion protein.
Expression and purification of RECQL4 and p300 proteins
GST-p300 and GST-RECQL4 protein fragments were expressed in E. coli BL21(DE3)
(Novagen) using the plasmid constructs described above. Overnight cultures grown
in Luria broth at 37°C were diluted 1:100 into fresh medium and incubated until
OD600 reached 0.6. Isopropyl-β-D-thiogalactoside (IPTG) was added to a final
concentration of 0.5 mM, and the cultures were incubated at 16°C for 20 hours. Cells
were harvested by centrifugation and re-suspended in buffer A [50 mM Tris-HCl (pH
8), 50 mM NaCl, 20% (v/v) glycerol supplemented with 1 μg/ml bestatin, leupeptin
and pepstatin protease inhibitors]. All subsequent steps were performed at 4°C or on
ice. Following sonication (815 second bursts with 5 second cooling), lysates were
clarified by centrifugation (50,000 g for 45 minutes) and added to glutathione
Sepharose 4B beads (GE Healthcare). After washing with buffer A supplemented
with 140 mM NaCl and 0.2% (v/v) Triton X-100, bound proteins were eluted with
buffer A containing 10 mM glutathione. Proteins were dialyzed overnight against
buffer B [20 mM Tris (pH 8), 200 mM NaCl, 1 mM EDTA, 0.5% (v/v) NP40, 0.5
mM PMSF, 20% (v/v) glycerol] and stored at –80°C.
The full-length RECQL4 protein was produced in BL21(DE3)Rosetta-pLysS cells
using the pET21b-GST-RECQL4-(His)6 construct under conditions described above.
Cells from a 12-liter culture were harvested by centrifugation, resuspended in 300
ml of buffer C [10 mM Tris-HCl (pH 8.1), 30 mM KH2PO4, 0.5 M NaCl, 10% (v/v)
glycerol, 20 mM imidazole supplemented with 1 mM PMSF and 2 μg/ml of each
bestatin, leupeptin and pepstatin] and disrupted by French press. After centrifugation
(20,000 rpm for 2 hours at 4°C; SS-34 rotor), the supernatant was loaded on a 1-ml
HiTrapHis column (GE Healthcare). The column was washed with 30 ml of buffer
C supplemented with 60 mM imidazole. Protein was eluted with buffer C
supplemented with 300 mM imidazole. RECQL4-containing fractions were pooled,
dialyzed against buffer D [50 mM Tris-HCl (pH 8), 150 mM NaCl, 1 mM DTT, 10%
(v/v) glycerol, 0.5 mM PMSF and 1 μg/ml of each bestatin, leupeptin and pepstatin]
and applied onto a 1-ml GST-Sepharose HiTrap column (GE Healthcare). After
washing with 30 ml buffer D containing 0.2% Triton X-100, bound proteins were
eluted by buffer D supplemented with 10 mM glutathione. Fractions containing
RECQL4 protein were pooled, dialyzed against buffer E [50 mM Tris-HCl (pH 8),
150 mM NaCl, 1 mM DTT, 1 mM EDTA, 40 % (v/v) glycerol and protease inhibitors]
and stored at –80°C.
Full-length p300 was produced in Sf9 cells and purified as previously described
(Hasan et al., 2002).
GST pull-down assays
HEK 293T whole-cell extracts, containing overexpressed full-length RECQL4 or p300
(500 μg of total protein), were incubated with 10 μg of purified GST-p300 or GST-
RECQL4 protein fragments (or GST alone), 50 μl glutathione-Sepharose 4B beads
(GE Healthcare), and 100 μg/ml ethidium bromide in buffer B in a total reaction
volume of 600 μl. Bound proteins were eluted with 30 μl Laemmli buffer, boiled for
5 minutes at 100°C and subjected to western blot analysis using anti-RECQL4 (rabbit
polyclonal, ab34800-100, Abcam) or anti-p300 antibodies (mouse polyclonal, ab3164-
500, Abcam).
Cell culture and indirect immunofluorescence microscopy
U2OS, HEK 293T and HeLa cells were maintained in Dulbecco’s modified Eagle’s
medium (Gibco) supplemented with 10% bovine fetal serum and 1% penicillin-
streptomycin in 5% CO2 atmosphere at 37°C. At 50% confluency, cells grown on
glass slides were transiently transfected with 2 μg of appropriate plasmid DNA using
Metafectene (Biontex).
For indirect immunofluorescence assays, cells growing on glass slides were
incubated in PBS for 5 minutes, fixed with methanol (30 minutes at –20°C), and
washed in acetone (30 seconds at –20°C). After a blocking step (5% BSA in PBS,
20 minutes at room temperature), slides were incubated with a mixture of appropriate
antibodies (anti-Omni-probe, 1:200, goat polyclonal, sc-499-6, Santa Cruz; anti-
FLAG, 1:2000, mouse polyclonal, F-1804, Sigma; anti-β-galactosidase, 1:5000, rabbit
polyclonal, ab616, Abcam). Rabbit antibodies were detected with Alexa-Fluor-488-
conjugated goat anti-rabbit IgG (1:400 in blocking buffer, Molecular Probes), the
goat antibodies were detected with Alexa-Fluor-546-conjugated donkey anti-goat IgG
(1:400 in blocking buffer, Molecular Probes), and mouse antibodies were detected
with AlexaFluor 488-conjugated donkey anti-mouse IgG (1:400 in blocking buffer,
Molecular Probes). To visualize nuclear DNA, slides were incubated with DAPI (0.4
μg/ml). After washing, slides were mounted in Vectashield (Vector Laboratories) and
viewed under a ZEISS Axiovert 200M microscope. Images were processed by
Axiovision software. For statistical analysis at least 200 cells were counted in two
independent experiments.
Synchronization of cells and DNA damaging treatments
HEK 293T cells growing exponentially (25% confluency) were transiently transfected
with the plasmids (5 μg each) expressing (His)6-Xpress-RECQL4 or FLAG-p300,
using the calcium phosphate transfection method. For G1-S phase synchronization,
24 hours after transfection, cells were grown for 16 hours in the presence of 2 mM
hydroxyurea. After block release, cells were collected at 3-hour intervals for up to
12 hours. Cell-cycle status of the individual samples was determined by flow cytometry
analysis of propidium iodine-stained cells. To induce DNA damage, 24 hours after
transfection, cells were treated with 1 μM campothecin, 10 μM cisplatin or 10 μM
etoposide for 12 hours before harvesting.
Co-immunoprecipitation experiments
Whole cell extracts, supplemented with ethidium bromide (100 μg/ml), containing
ectopically expressed (His)6-Xpress-RECQL4 (1 mg of total protein) or FLAG-p300
(1.5 mg of total protein) were incubated with 1.5 μg of anti-p300 antibody (mouse
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polyclonal, ab3164-500, Abcam) or 1.5 μg of anti-RECQL4 antibody (rabbit
polyclonal, ab34800-100, Abcam), respectively. Immune complexes were bound to
protein A/G-Agarose beads (Santa Cruz) for 4 hours at 4°C. The final volume was
raised to 1 ml with IP buffer [20 mM HEPES (pH 7.5), 5 mM MgCl2, 150 mM NaCl,
0.1% (w/v) NP40, supplemented with 1 μg/ml bestatin, leupeptin and pepstatin].
Immunoprecipitated p300 or RECQL4 proteins were detected by western blot analysis
using the above antibodies, and co-immunoprecipitated (His)6-Xpress-RECQL4 and
FLAG-p300 proteins were detected using Omni-probe (goat polyclonal, sc-499-G,
Santa Cruz) and anti-FLAG (mouse, polyclonal, F-1804, Sigma) antibodies,
respectively.
ELISA-based protein binding
Purified recombinant p300 was diluted to a concentration of 20 nM in carbonate
buffer [16 mM Na2CO3, 34 mM NaHCO3 (pH 9.6)] and added to wells of a 96-well
microtiter plate (50 μl/well). Plates were incubated overnight at 4°C. For control
reactions, wells were precoated with an equivalent amount of bovine serum albumin
(BSA). After aspiration of the samples, the wells were blocked with blocking buffer
[phosphate-buffered saline, 0.5% (v/v) Tween 20, and 3% (w/v) BSA] for 2 hours
at 37°C (200 μl/well)]. Following blockage, the wells were incubated with increasing
concentrations of purified recombinant RECQL4 protein for 1 hour at 37°C. Wells
were washed four times with blocking buffer to eliminate unbound proteins and
incubated with RECQL4 antibody (rabbit polyclonal, 1:2000, ab34800-100, Abcam)
diluted in blocking buffer. Plates were incubated for 1 hour at 37°C. After four
washings with blocking buffer, horseradish peroxidase-conjugated anti-rabbit
secondary antibody (1:10,000 in blocking buffer) was added and the plates were
incubated at 37°C for 30 minutes. After extensive washing with blocking buffer, the
protein complexes were detected using o-phenylenediamine dichloride (Sigma)
dissolved in 0.1 M citrate phosphate buffer (pH 5.0) containing 0.03% hydrogen
peroxide (1 mg/ml). The reactions were terminated after 10 minutes by adding 50
μl of 2 M H2SO4. The plates were scanned in a microplate reader (Molecular Devices)
for absorbance at 450 nm. The A450 values, corrected for background signal in the
presence of BSA, were plotted as a function of the concentration of RECQL4 protein
using the GraphPad Prism software.
In vivo acetylation assay
Total protein extract from HEK 293T cells (1 mg of total protein), ectopically
expressing (His)6-Xpress-RECQL4 and one of the selected histone acetyltransferases
(p300, GCN5, PCAF, HAT1), was incubated for 4 hours at 4°C with 2 μg of Omni-
probe antibody (goat polyclonal, sc-499-G, Santa Cruz) bound to protein A/G-Agarose
beads (Santa Cruz). Immunoprecipitated RECQL4 protein was detected by western
blot analysis using the Omni-probe antibody. The membrane was stripped in 50 mM
Tris pH 8, 5 mM β-mercaptoethanol, 2% sodium dodecyl sulfate for 1 hour at 52°C.
Acetylated lysine residues were visualized by rabbit polyclonal anti-acetylated lysine
antibody (9441-5, Cell Signaling; 1:1000).
In vitro acetylation assay
Purified GST-RECQL4 fragments (1 μg) were incubated with 0.1 μCi [14C] acetyl
coenzyme A (CFA390, Amersham Biosciences) and purified p300 (1 μg) in 30 μl
HAT-Buffer [50 mM Tris-HCl (pH 8.0), 10% (v/v) glycerol, 150 mM NaCl, 1 mM
DTT, 1 mM PMSF, 10 mM Na butyrate] at 30°C for 1 hour. The reactions were
subjected to SDS-PAGE analysis. Gels were stained with Coomassie blue and
subsequently subjected to autoradiography. The film was developed after 24 hours
of incubation at –80°C.
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